Deep learning based prediction of reversible HAT/HDAC-specific lysine acetylation

Kai Yu1, Qingfeng Zhang1, Zekun Liu1

  • 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Briefings in Bioinformatics
|September 26, 2020
PubMed
Summary

Deep-PLA software predicts enzyme-specific protein lysine acetylation, aiding cancer research. It identifies how histone acetyltransferase (HAT) and histone deacetylase (HDAC) modifications impact cancer signaling pathways.